Last updated 2026-09-02
- Acquired by Vishay Intertechnology, Mar 2004
Total raised
—
Stage
Acquired
Founded
1998
Headcount
—
HQ
Or Yehuda, Israel
Sector
Industrial Technologies
About
RFWaves develops short-range wireless technology, focusing on low-cost, low-power fabless semiconductor solutions for the consumer electronics market. Its products enable wireless transfer rates of up to 1 megabyte per second, with applications ranging from wireless peripherals, headsets, earphones, and toys to more complex uses in healthcare and automation.
Offices
Or Yehuda, Israel · HQ / main office
Q&A
- What is RFWaves' primary business?
- RFWaves develops short-range wireless communications modules that can transmit information in two directions without a line-of-sight, with minimal electrical current. These components can be integrated into home and office multimedia systems, security installations, and toys.
- What is the current status of RFWaves?
- RFWaves was acquired by Vishay Intertechnology in March 2004 and is currently inactive.
- Who acquired RFWaves and when?
- RFWaves was acquired by Vishay Intertechnology in March 2004.
- How much total funding did RFWaves raise?
- RFWaves raised a total of $15,000,000.
- Which investors participated in RFWaves' B Round funding?
- Sequoia Capital participated in RFWaves' B Round funding in July 2002.
- Who are the founders of RFWaves?
- The founders of RFWaves are Gideon Barak and Moshe Lerner.
Team · 5
Gideon Barak
Founder · Founder
Moshe Lerner
Founder · Founder
David Ben-Bassat
CEO
Avner Divon
Chairman
Barry Volinsky
VP Marketing
Sectors & technology
Primary sector
Industrial Technologies
Technologies
Target customers
Business model
B2B
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 1998 |
|---|---|
| Status reason | Acquired (Inactive) by Vishay Intertechnology on Mar 2004 - closed due to acquisition |
Acquisitions & public offerings
Acquired by Vishay Intertechnology 2004-03
Radar intelligence
Patents
| EPO | 2 |
|---|